The American Society of Radiologic Technologists (ASRT), in Albuquerque, N.M., was recently recognized by the Albuquerque Journal as a 2025 Top Workplace in the 35-150 employee category.

ASRT staff completed a confidential employee engagement survey from an independent research company in January 2025. The survey measured various drivers of engaged work cultures that are critical to the success of any organization, including culture, environment and benefits/compensation. 

July 14, 2025 — Patients with liver diseases will have expanded access to advanced ultrasound imaging and transplant options, thanks to new policy allowing doctors to use contrast-enhanced ultrasound (CEUS) to help assess certain liver cancers and determine whether a liver is healthy enough for transplantation, according to experts affiliated with the International Contrast Ultrasound Society (ICUS).

July 10, 2025 — Bracco Imaging was recently awarded a Platinum Medal by EcoVadis, one of the world's most trusted business sustainability rating platforms. The award highlights Bracco's growing commitment to environmental and social responsibility—and positions the company among a select group of global organizations demonstrating leadership in sustainable business practices.

July 10, 2025 — Fujifilm Healthcare Americas Corp. has launched several advanced automated functions for its FDR Visionary Suite digital radiography room. Optimized to support high-volume imaging in hospital radiology departments and imaging centers, the automation features are designed to enhance workflow and improve the patient and technologist experience for a wide range of general radiology exams.

June 9, 2025 — bioAffinity Technologies, Inc., a biotechnology company addressing the need for noninvasive, accurate tests for the detection of early-stage cancer, has released a new case study of a complex clinical case in which CyPath Lung identified Stage 1A adenocarcinoma lung cancer in a patient whose PET imaging and risk model probability indicated a low risk of malignancy.

July 9, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, recently announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ArteraAI Prostate, an AI precision medicine tool intended to assist clinicians with risk-based decisions for patients with localized prostate cancer.

July 9, 2025 — The American Society for Radiation Oncology (ASTRO) selected 43 members to receive the ASTRO Fellow (FASTRO) designation this year. This prestigious honor recognizes ASTRO members’ outstanding achievements and contributions to the Society, cancer research, education, patient care and the specialty. The new Fellows will be recognized at ASTRO’s 67th Annual Meeting in San Francisco in September.

July 8, 2025 — QT Imaging Holdings, has appointed Elaine Iuanow, MD, as chief medical officer (CMO) and Kim Du as senior director of clinical operations. These additions to the leadership team significantly enhance the company’s medical and clinical capabilities as QTI expands its clinical studies as well as the development of AI-driven lesion classification and second-read decision support tools alongside the commercialization of its FDA-cleared QTI Breast Acoustic CT™ scanner.

July 2, 2025 — Lunit, a provider of AI for cancer diagnostics and therapeutics, has announced a collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions. In conjunction with their recent acquisition of Volpara, a Microsoft Industry Health Certified Partner, this collaboration will give health professionals globally access to tools that will assist in the detection of cancer.

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has launched Mammogram+ and Mammogram+ Heart, two new AI-enhanced mammogram services aimed at improving early detection and advancing preventative care.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now